Hayley King
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hayley King has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
A. Toby A. Jenkins
Department of Chemistry, University of Bath, BA2 7AY, United Kingdom
1 shared publicationAbbie Greenhill
Bristol Medical School, University of Bristol, Bristol, UK
1 shared publicationAidan Grimes
Bristol Medical School, University of Bristol, Bristol, UK
1 shared publicationAmber Young
Children's Burns Research Centre, Bristol Royal Hospital for Children, Bristol BS2 8BJ, United Kingdom; Bristol Centre for Surgical Research, Canynge Hall, University of Bristol, Bristol BS8 2PS, United Kingdom
1 shared publication- Amberly Brigden
School of Engineering Mathematics and Technology, University of Bristol, Bristol, United Kingdom
1 shared publication - Anna Davies
Academic Women’s Health Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
1 shared publication
Latest Publications
- 12 September 2024
- Published by BMJ in Archives of Disease in Childhood
- Vol. 109 (11) , 961-962
Ceftriaxone to enable paediatric outpatient antimicrobial treatment (OPAT) in neonates
- 12 September 2024
- Published by BMJ in Archives of Disease in Childhood
- Vol. 109 (11) , 961-962
Ceftriaxone to enable paediatric outpatient antimicrobial treatment (OPAT) in neonates
- 19 March 2024
- Published by BMJ in Archives of Disease in Childhood - Education & Practice Edition
- Vol. 109 (3) , 137-142
Interpretation: use of autoantibodies in children
Judicious use of autoantibodies in paediatrics can be challenging. Autoimmune conditions can present with a wide range of signs and symptoms, many of which are non-specific. In combination with clinical features and laboratory findings, autoantibodies can facilitate diagnosis and in certain cases inform prognosis. Evidence for use of autoantibodies to guide and monitor treatment is limited. Caution is necessary when interpreting adult studies. We summarise the use of autoantibodies in paediatric practice with a guide on how they may be used.
- 19 March 2024
- Published by BMJ in Archives of Disease in Childhood - Education & Practice Edition
- Vol. 109 (3) , 137-142
Interpretation: use of autoantibodies in children
Judicious use of autoantibodies in paediatrics can be challenging. Autoimmune conditions can present with a wide range of signs and symptoms, many of which are non-specific. In combination with clinical features and laboratory findings, autoantibodies can facilitate diagnosis and in certain cases inform prognosis. Evidence for use of autoantibodies to guide and monitor treatment is limited. Caution is necessary when interpreting adult studies. We summarise the use of autoantibodies in paediatric practice with a guide on how they may be used.
- Open Access
- 1 June 2019
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 14, 100335
Treatment preference and recruitment to pediatric RCTs: A systematic review
- 1 June 2019
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 14, 100335
Open AccessTreatment preference and recruitment to pediatric RCTs: A systematic review